(Axios) – Patients prescribed highly effective anti-obesity medications are growing anxious about the increasing difficulty of obtaining them amid long-running shortages driven by blockbuster demand for the drugs. Why it matters: Their ongoing struggle to locate reliable supplies of drugs like Novo Nordisk’s Wegovy is fueling fears among patients that even a brief disruption to their dosing schedule could set back their progress, doctors who prescribe the drugs told Axios. (Read More)